Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Pure Extracts Technologies Corp. (CSE: PULL) Names Key Advisor; Targets Development of Mushroom Formulations

Pure Extracts is working with Dr. Alexander MacGregor on development of mushroom products, including some combined with CBD. MacGregor is widely renowned as pharmaceutical science inventor, expert in pharmaceutical technology and novel drug-delivery systems. Pure Extracts is focused on expansion of its cannabis extraction business model to include mushroom formulations. Pure Extracts Technologies (CSE: PULL) […]

Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Begins Review of Strategy for Increased Investor Profile in US, Potential NASDAQ Bid

Clean Power Capital Corp. (formerly known as Organic Flower Investments Group Inc.) is a British Columbia-based holding company with investments in a variety of sectors and a growing interest in the U.S. marketplace The company recently announced the formation of a strategic committee to examine possibilities for building its investor profile in the United States, […]

Knightscope’s AI-enhanced Security Robots Address Concerns Surrounding Business Protection Industry

Knightscope is a private industry security robot developer pioneering autonomous solutions to many long-standing concerns with corporate facility protection These robots’ ability to perform repetitive, often boring and sometimes dangerous tasks makes them ideally suited for property patrolling, and their capacity for analyzing and recording their interactions qualifies them for actual crime prevention and reporting […]

Pure Extract Technologies (CSE: PULL) Provides Update on Expansion into Functional Mushrooms Sector

Pure Extracts Technologies recently provided update into its expansion into functional mushrooms sector Functional mushrooms have enjoyed surge in popularity as of late, are increasingly being used in wide variety of healthcare, pharmaceutical products Functional mushrooms sector is expected to grow to annual market value of $34.4 billion by 2024 Pure Extracts plans to develop […]

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes it Easier to See the Invisible in Cancer Surgery

Imagin Medical Inc. is a surgical imaging company building a platform of technological products designed to improve endoscopic surgeries through adaptable equipment that makes it easier to see anomalies such as cancerous tumors The company’s initial product launch will focus on bladder cancers visible under blue light thanks to a dye on the market that […]

Predictive Oncology (NASDAQ: POAI) Leverages Precision Medicine Expertise to Support Oncologists, Improve Patient Outcomes

Precision medicine is emerging approach to disease prevention, treatment that incorporates individual’s distinctive characteristics. New approach allows doctors, researchers to predict more accurately which treatments may work better. Helomics’ database, largest of its kind, is comprised of ovarian, head and neck, colon and pancreas tumors. Science has discovered that thumbprints and DNA aren’t the only […]

Anticipating Significant 2021 Growth, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Announces Major Uplisting Plans

Company plans to first uplist to TSX from its current TSX.V listing. Uplisting benefits include enhanced visibility and potentially increased access to capital If TSX uplisting is successful, Loop has plans for a possible dual listing by filing with the SEC and NASDAQ Company anticipates significant growth to continue in 2021, following an increase in […]

 

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

June 26, 2026

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings (NASDAQ: CDIO) reports that approximately 50% of individuals with coronary heart disease do not present with traditional risk […]

Rotate your device 90° to view site.